Fig. 6From: Impact of AADAC gene expression on prognosis in patients with Borrmann type III advanced gastric cancerNomogram models predicting the overall survival and disease-free survival of patients. a Nomogram model predicting the 3- and 5-year overall survival of patients with Borrmann type III AGC. b ROC curve of the nomogram model predicting the 3-year overall survival of patients. c ROC curve of the nomogram model predicting the 5-year overall survival of patients. ROC: receiver operating characteristic, CA19-9: carbohydrate antigen 19-9Back to article page